1

Obinutuzumab (GA101): A Comprehensive Overview

949142501869759
Obinutuzumab, also known as GA101, represents an novel monoclonal antibody designed in treat CLL. It targets CD20 expressed on B lymphocytes, resulting in antibody-dependent cell-mediated cytotoxicity and destruction. https://www.targetmol.com/compound/obinutuzumab
Report this page

Comments

    HTML is allowed

Who Upvoted this Story